Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3329684 | Critical Reviews in Oncology/Hematology | 2009 | 10 Pages |
Abstract
Tumor hypoxia is a common feature of many cancers. A master regulator of hypoxic response is the transcription factor hypoxia-inducible factor-1 (HIF-1). It functions as a master regulator of oxygen and undergoes conformational changes in response to varying oxygen concentrations. In this paper, we review what has been described about HIF-1: its structure, its regulation and target genes, its role in cancer, and its implication for cancer therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Zaher K. Otrock, Hassan A. Hatoum, Ahmad H. Awada, Rim S. Ishak, Ali I. Shamseddine,